Licochalcone A suppresses Sp1 expression with potential anti-myeloma activity.

Bai, Hua; Zhou, Min; Zhou, He; Han, Qiaoyan; Xu, Han; Xu, Peipei; Chen, Bing

Bai, Hua; Zhou, Min; Zhou, He; Han, Qiaoyan; Xu, Han; Xu, Peipei; Chen, Bing.

Afiliação

Bai H; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
Zhou M; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
Zhou H; Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, P. R. China.
Han Q; Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, P. R. China.
Xu H; School of Medicine, Southeast University, Nanjing, Jiangsu, 210008, P. R. China.
Xu P; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
Chen B; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.

Cancer Commun (Lond) ; 41(11): 1239-1242, 2021 11.

Article em En | MEDLINE | ID: mdl-34665930

Assuntos

Chalconas; Mieloma Múltiplo; Chalconas/farmacologia; Chalconas/uso terapêutico; Humanos; Mieloma Múltiplo/tratamento farmacológico; Fator de Transcrição Sp1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Chalconas / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google